Back to search

Article

Sequential screening nominates the Parkinson’s disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis

2020-04-30

Abstract excerpt

Mutations in leucine-rich repeat kinase 2 ( LRRK2 ) are an established cause of inherited Parkinson’s disease (PD). LRRK2 is expressed in both neurons and glia in the central nervous system, but its physiological function(s) in each of these cell types is uncertain. Through sequential screens, we report a functional interaction between LRRK2 and Clathrin adaptor protein complex 2 (AP2). Analysis of LRRK2 KO tissu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c77a5382-3e46-5e0f-b301-7f62649223cd
DOI
10.1101/2020.04.28.053660
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sequential screening nominates the Parkinson’s disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosisDOI 10.1101/2020.04.28.053660
Select a neighboring publication to make it the new centre.